Home > Injectable APIs > Sterile API Production
Sterile API Production
At Abiozen, sterile active pharmaceutical ingredient (API) production forms the backbone of our injectable drug development platform. We specialize in the manufacture of high-purity sterile APIs optimized for both clinical and commercial use. Leveraging best-in-class practices from leading CDMO organizations such as Curia Global, Thermo Fisher Patheon, and Thermo Fisher CRDMO, our operations are engineered to exceed international expectations across safety, efficacy, and scalability.
World-Class Infrastructure and Automation
Our ISO Class 5 (Grade A) cleanrooms ensure an ultra-low particulate environment, continuously monitored by advanced particle counters and microbial air samplers. These stringent conditions virtually eliminate contamination risks. Robotic automated filling lines further minimize human intervention, delivering precise, consistent vial dosing from 2 mL to 100 mL. Multi-layered in-line filtration and sterilization systems, including 0.22-micron filters and sterilization via autoclaving or gamma irradiation, guarantee final product sterility.
High-Purity Production with Real-Time Quality Assurance
Abiozen delivers API purity exceeding 99.5%, validated through high-performance liquid chromatography (HPLC) and mass spectrometry (MS). In-line sensors and automated data logging support real-time quality checks at every stage of production, ensuring each batch is manufactured with exceptional precision and consistency.
Scalable and Adaptive Manufacturing
Our production model supports seamless scalability—from 1 kg R&D-scale batches to 1,000 kg commercial runs—while maintaining rigorous quality standards. Rapid reconfiguration capabilities enable us to meet the evolving needs of pharmaceutical innovators with efficiency and speed.
Regulatory Excellence and Inspection Readiness
We maintain full compliance with USFDA, EMA, cGMP, and ICH guidelines. Our regulatory affairs team ensures all documentation is complete and inspection-ready, including electronic batch records (eBRs) and comprehensive audit trails. This robust compliance framework enables Abiozen to serve as a trusted sterile API manufacturing partner across regulated global markets.
Connect with Abiozen
We thrive on tackling complex challenges—and we’d love to learn about yours. Reach out to explore how we can support your program’s unique requirements.
Related Resources

Sterility Validation: Testing per USP <71> and EP 2.6.1 guarantees the absence of microbial contamination, essential for injectable products.
absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste management systems to uphold safety and environmental standards. real-time environmental monitoring to guarantee sterility. rapid delivery

Residual Solvent Testing: Gas chromatography (GC) confirms compliance with ICH Q3C guidelines, ensuring safety and purity.
compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste management systems to uphold safety and environmental standards. real-time environmental monitoring to guarantee sterility. rapid delivery of clinical and commercial batches. (up to 2,000

Moisture Content Analysis: Using Karl Fischer titration, we achieve residual moisture levels below 1%, critical for long-term stability.
residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste management systems to uphold safety and environmental standards. real-time environmental monitoring to guarantee sterility. rapid delivery of clinical and commercial batches. (up to 2,000 L) to eliminate cross-contamination risks and enable flexible manufacturing.

Sterility Validation: Testing per USP <71> and EP 2.6.1 guarantees the absence of microbial contamination, essential for injectable products.
absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste management systems to uphold safety and environmental standards. real-time environmental monitoring to guarantee sterility. rapid delivery

Residual Solvent Testing: Gas chromatography (GC) confirms compliance with ICH Q3C guidelines, ensuring safety and purity.
compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste management systems to uphold safety and environmental standards. real-time environmental monitoring to guarantee sterility. rapid delivery of clinical and commercial batches. (up to 2,000

Sterility Validation: Testing per USP <71> and EP 2.6.1 guarantees the absence of microbial contamination, essential for injectable products.
absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste management systems to uphold safety and environmental standards. real-time environmental monitoring to guarantee sterility. rapid delivery